196 related articles for article (PubMed ID: 18450391)
1. Role of breast cancer resistance protein (Bcrp/Abcg2) in fetal protection during gestation in rat.
Cygalova L; Ceckova M; Pavek P; Staud F
Toxicol Lett; 2008 May; 178(3):176-80. PubMed ID: 18450391
[TBL] [Abstract][Full Text] [Related]
2. Expression and transport activity of breast cancer resistance protein (Bcrp/Abcg2) in dually perfused rat placenta and HRP-1 cell line.
Staud F; Vackova Z; Pospechova K; Pavek P; Ceckova M; Libra A; Cygalova L; Nachtigal P; Fendrich Z
J Pharmacol Exp Ther; 2006 Oct; 319(1):53-62. PubMed ID: 16809480
[TBL] [Abstract][Full Text] [Related]
3. Effect of oxygen on multidrug resistance in the first trimester human placenta.
Lye P; Bloise E; Dunk C; Javam M; Gibb W; Lye SJ; Matthews SG
Placenta; 2013 Sep; 34(9):817-23. PubMed ID: 23790363
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer resistance protein (Bcrp1/Abcg2) in mouse placenta and yolk sac: ontogeny and its regulation by progesterone.
Kalabis GM; Petropoulos S; Gibb W; Matthews SG
Placenta; 2007 Oct; 28(10):1073-81. PubMed ID: 17524480
[TBL] [Abstract][Full Text] [Related]
5. Fetoprotective activity of breast cancer resistance protein (BCRP, ABCG2): expression and function throughout pregnancy.
Hahnova-Cygalova L; Ceckova M; Staud F
Drug Metab Rev; 2011 Feb; 43(1):53-68. PubMed ID: 20854129
[TBL] [Abstract][Full Text] [Related]
6. Expression of breast cancer resistance protein (BCRP/ABCG2) in human placenta throughout gestation and at term before and after labor.
Yeboah D; Sun M; Kingdom J; Baczyk D; Lye SJ; Matthews SG; Gibb W
Can J Physiol Pharmacol; 2006 Dec; 84(12):1251-8. PubMed ID: 17487233
[TBL] [Abstract][Full Text] [Related]
7. The effect of acetaminophen on the expression of BCRP in trophoblast cells impairs the placental barrier to bile acids during maternal cholestasis.
Blazquez AG; Briz O; Gonzalez-Sanchez E; Perez MJ; Ghanem CI; Marin JJ
Toxicol Appl Pharmacol; 2014 May; 277(1):77-85. PubMed ID: 24631341
[TBL] [Abstract][Full Text] [Related]
8. An update on expression and function of P-gp/ABCB1 and BCRP/ABCG2 in the placenta and fetus.
Han LW; Gao C; Mao Q
Expert Opin Drug Metab Toxicol; 2018 Aug; 14(8):817-829. PubMed ID: 30010462
[TBL] [Abstract][Full Text] [Related]
9. Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo.
Ceckova M; Libra A; Pavek P; Nachtigal P; Brabec M; Fuchs R; Staud F
Clin Exp Pharmacol Physiol; 2006; 33(1-2):58-65. PubMed ID: 16445700
[TBL] [Abstract][Full Text] [Related]
10. Effect of oxygen on multidrug resistance in term human placenta.
Javam M; Audette MC; Iqbal M; Bloise E; Gibb W; Matthews SG
Placenta; 2014 May; 35(5):324-30. PubMed ID: 24685282
[TBL] [Abstract][Full Text] [Related]
11. Long-term administration of tenofovir or emtricitabine to pregnant rats; effect on Abcb1a, Abcb1b and Abcg2 expression in the placenta and in maternal and fetal organs.
Cerveny L; Neumanova Z; Karbanova S; Havlova I; Staud F
J Pharm Pharmacol; 2016 Jan; 68(1):84-92. PubMed ID: 26727197
[TBL] [Abstract][Full Text] [Related]
12. Placental P-glycoprotein and breast cancer resistance protein: influence of polymorphisms on fetal drug exposure and physiology.
Hutson JR; Koren G; Matthews SG
Placenta; 2010 May; 31(5):351-7. PubMed ID: 20347140
[TBL] [Abstract][Full Text] [Related]
13. Gestational and pregnane X receptor-mediated regulation of placental ATP-binding cassette drug transporters in mice.
Gahir SS; Piquette-Miller M
Drug Metab Dispos; 2011 Mar; 39(3):465-71. PubMed ID: 21127142
[TBL] [Abstract][Full Text] [Related]
14. The role of placental breast cancer resistance protein in the efflux of glyburide across the human placenta.
Pollex E; Lubetsky A; Koren G
Placenta; 2008 Aug; 29(8):743-7. PubMed ID: 18558430
[TBL] [Abstract][Full Text] [Related]
15. The ABC transporter BCRP/ABCG2 is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction.
Evseenko DA; Murthi P; Paxton JW; Reid G; Emerald BS; Mohankumar KM; Lobie PE; Brennecke SP; Kalionis B; Keelan JA
FASEB J; 2007 Nov; 21(13):3592-605. PubMed ID: 17595345
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer resistance protein 1 limits fetal distribution of nitrofurantoin in the pregnant mouse.
Zhang Y; Wang H; Unadkat JD; Mao Q
Drug Metab Dispos; 2007 Dec; 35(12):2154-8. PubMed ID: 17785426
[TBL] [Abstract][Full Text] [Related]
17. Placental BCRP/ABCG2 Transporter Prevents Fetal Exposure to the Estrogenic Mycotoxin Zearalenone.
Szilagyi JT; Gorczyca L; Brinker A; Buckley B; Laskin JD; Aleksunes LM
Toxicol Sci; 2019 Apr; 168(2):394-404. PubMed ID: 30576553
[TBL] [Abstract][Full Text] [Related]
18. Regulation of BCRP/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells.
Wang H; Zhou L; Gupta A; Vethanayagam RR; Zhang Y; Unadkat JD; Mao Q
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E798-807. PubMed ID: 16352672
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid regulation of placental breast cancer resistance protein (Bcrp1) in the mouse.
Petropoulos S; Gibb W; Matthews SG
Reprod Sci; 2011 Jul; 18(7):631-9. PubMed ID: 21602547
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor-mediated activation of the map kinase cascade results in altered expression and function of ABCG2 (BCRP).
Meyer zu Schwabedissen HE; Grube M; Dreisbach A; Jedlitschky G; Meissner K; Linnemann K; Fusch C; Ritter CA; Völker U; Kroemer HK
Drug Metab Dispos; 2006 Apr; 34(4):524-33. PubMed ID: 16415123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
